Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Douglas Lauffenburger
 

Douglas Lauffenburger

 
Member - Scientific Advisory Board - Merrimack Pharmaceuticals Inc.
 
Douglas Lauffenburger Email :
Please login
 
Company Name : Merrimack Pharmaceuticals Inc.
 
Company Website : www.merrimackpharma.com
 
Company Address : Bldg. 700
2nd Fl., Cambridge, MA,
United States,
 
Douglas Lauffenburger Profile :
Member - Scientific Advisory Board - Merrimack Pharmaceuticals Inc.
 
Douglas Lauffenburger Biography :

Douglas A. Lauffenburger, Ph.D. is Uncas & Helen Whitaker Professor of Bioengineering and Director of the Biological Engineering Division at MIT, and also holds appointments in the Department of Biology and the Department of Chemical Engineering. Dr. Lauffenburger's BS and PhD degrees are in chemical engineering from the University of Illinois and the University of Minnesota, in 1975 and 1979 respectively. His major research interests are in cell engineering: the fusion of engineering with molecular cell biology. A central focus of his research program is in receptor-mediated cell communication and intracellular signal transduction, with emphasis on development of predictive computational models derived from quantitative experimental studies, for cell cue/signal/response relationships important in pathophysiology with application to drug discovery and development.

 
Douglas Lauffenburger Colleagues :
Name Title Email

Robert Mulroy

Board Dir., CEO, Pres. Please login

Lisa Evren

Exec. VP, CFO Please login

William Slichenmyer

Sr. VP, Chief Medical Officer Please login

Ulrik Nielsen

VP - Research Please login

Fazal Khan

VP - Manufacturing Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.